Poisoning & Overdose EMERGENCY
GCC Emergency Nursing Guide  |  Evidence-Based Clinical Reference  |  DHA / DOH / SCFHS Exam Ready

Initial Assessment — ABCDE Primary Survey

A — Airway

  • Assess patency; suction secretions
  • GCS <8 or inability to protect — consider intubation
  • Position: recovery position if semi-conscious
  • Corrosive ingestion: avoid NG tube until assessed

B — Breathing

  • RR, SpO2, auscultation bilaterally
  • Opioid: bradypnea/apnoea — naloxone
  • Salicylate: tachypnoea/Kussmaul breathing
  • Apply 15L O2 via NRB if CO suspected

C — Circulation

  • HR, BP, capillary refill, ECG — 12 lead stat
  • QTc prolongation: TCA, antipsychotics, antihistamines
  • Wide QRS (>120ms): TCA — give NaHCO3
  • Bradycardia: beta-blocker, CCB, digoxin, organophosphate
  • IV access x2 large bore; bloods including paracetamol/salicylate levels

D — Disability (Neuro)

  • GCS — document fully (E/V/M)
  • Pupils: pinpoint (opioid/organophosphate) vs dilated (anticholinergic/sympathomimetic)
  • BM — hypoglycaemia common (ethanol, insulin, salicylate)
  • Seizures: benzodiazepine first-line

E — Exposure & Environment

  • Full skin exam — patches, injection sites, burns
  • Temperature: hyperthermia (serotonin/NMS/anticholinergic) vs hypothermia (opioid/ethanol)
  • Decontaminate skin if organophosphate exposure (PPE for staff)
  • Remove contaminated clothing

Bloods to Request

  • FBC, U&E, LFTs, coagulation, glucose, lactate, ABG
  • Paracetamol + salicylate levels (all deliberate overdoses)
  • Ethanol level, urine drug screen
  • ECG, CXR if aspiration risk
Toxidrome Recognition Guide
Sympathomimetic
Agents: cocaine, amphetamines, MDMA
HR: Tachycardia  BP: Hypertensive
Pupils: Dilated (mydriasis)
Temp: Hyperthermia  Skin: Diaphoretic
Mental: Agitation, psychosis
Bowel: Hyperactive
Rx: Benzo for agitation, cooling
Cholinergic (SLUDGE/DUMBELS)
Agents: Organophosphates, carbamates
HR: Bradycardia  BP: Hypotension
Pupils: Pinpoint (miosis)
Secretions: Salivation, lacrimation, urination, defecation, emesis, bronchospasm
Muscle: Fasciculations, weakness
Rx: Atropine + Pralidoxime
Anticholinergic
Agents: TCA, antihistamines, atropine, hyoscine
HR: Tachycardia  BP: Variable
Pupils: Dilated  Skin: Dry/flushed
Temp: Hyperthermia  Bowel: Ileus
Mental: Confusion, delirium, hallucinations
Mnemonic: "Blind as a bat, dry as a bone, red as a beet, mad as a hatter"
Opioid
Agents: Morphine, codeine, heroin, fentanyl, tramadol
HR: Bradycardia  BP: Hypotension
Pupils: Pinpoint (miosis)
RR: Decreased/apnoea  Temp: Hypothermia
Mental: CNS depression, coma
Rx: Naloxone — titrate to RR
Sedative-Hypnotic
Agents: Benzodiazepines, barbiturates, GHB, ethanol
HR: Normal/slow  BP: Normal/low
Pupils: Normal  RR: Decreased
Mental: Sedation, ataxia, amnesia
Note: Pupils normal distinguishes from opioid
Rx: Supportive; flumazenil (caution)
Serotonin Syndrome
Agents: SSRIs, SNRIs, MAOIs, tramadol, fentanyl, linezolid
Triad: Mental status change + autonomic instability + neuromuscular abnormality
Key features: Clonus (especially lower limb), hyperreflexia, diaphoresis, hyperthermia, diarrhoea
Note: Rapid onset (hours) — distinguishes from NMS
Rx: Cyproheptadine, cooling, benzo
Neuroleptic Malignant Syndrome
Agents: Antipsychotics (haloperidol, olanzapine), metoclopramide
Onset: Days to weeks (slower than serotonin)
Features: Hyperthermia, "lead-pipe" rigidity, autonomic instability, elevated CK
Labs: Raised CK, leukocytosis, elevated LFTs
Rx: Stop antipsychotic, dantrolene, bromocriptine

History Taking — AMPLE + Tox

Agent

  • Name, formulation (IR vs modified-release)
  • Prescription vs OTC vs illicit
  • Any packaging available — bring to ED

Amount & Time

  • Estimated dose/number of tablets
  • Time of ingestion (single event vs staggered)
  • Staggered overdose: paracetamol nomogram unreliable

Route

  • Oral, IV, inhalation, transdermal, rectal

Co-ingestion

  • Alcohol commonly co-ingested — increases toxicity
  • Multiple agents alter clinical picture

Intent & Context

  • Deliberate self-harm vs accidental vs occupational
  • Witness history if patient unable to give history

Resources & Monitoring

TOXBASE / Poisons Information

  • TOXBASE (UK): toxbase.org — primary clinical resource
  • UAE: National Poison Control Centre — integrated into DHA/MOH systems
  • GCC hospitals should have 24hr poisons info access
  • Call toxicology/pharmacy for complex cases

ECG Monitoring — Key Findings

FindingConsider
QTc >500msTCA, antipsychotic, antihistamine, methadone
Wide QRS >120msTCA, flecainide — give NaHCO3
Bradycardia/AV blockBeta-blocker, CCB, digoxin, organophosphate
Tall T wavesDigoxin toxicity pattern
Ventricular arrhythmiaTCA, cocaine — assess QTc

Decontamination Indications

  • Activated charcoal: within 1 hour of significant ingestion
  • Whole bowel irrigation: body packers, iron, lithium, SR preparations
  • Skin decontamination: organophosphate, chemical exposure
Activated Charcoal — Indications & Contraindications

Indications

  • Toxic ingestion within 1 hour (occasionally up to 2hrs for modified-release)
  • Adult dose: 50g orally or via NGT
  • Paediatric: 1g/kg (max 50g)
  • Effective for: paracetamol, aspirin, most drugs
  • Multiple-dose AC: carbamazepine, phenobarbitone, quinine, theophylline

Contraindications (CAUTION)

  • Unconscious — aspiration risk (unless intubated)
  • Corrosive — acid/alkali ingestion (obscures endoscopy)
  • Hydrocarbons — petrol, turpentine (aspiration pneumonitis)
  • Iron — not adsorbed by charcoal
  • Lithium — not adsorbed by charcoal
  • Cyanide/Alcohols — poor adsorption
  • Unprotected airway — ensure GCS adequate or intubate first

Nursing: Give with antiemetic (ondansetron) — charcoal causes nausea. Document exact time given vs time of ingestion. Slurry via NGT if patient refuses. Black stools expected. Monitor for aspiration.

Whole Bowel Irrigation (WBI)

Indications

  • Body packers — concealed drug packets
  • Iron overdose — not adsorbed by charcoal
  • Lithium — SR formulations
  • Modified-release preparations (SR opioids, SR CCB)
  • Large ingestions where charcoal contraindicated

Protocol

  • Agent: Polyethylene glycol (PEG) — Klean-Prep / GoLytely
  • Rate: 2L/hr via NGT (adults); 500ml/hr (child)
  • Continue until rectal effluent clear
  • Position: upright 45° minimum

Contraindications

  • Bowel obstruction, perforation, ileus
  • Haemodynamically unstable
  • Compromised airway or unprotected airway

Body packer: Do NOT attempt forceful extraction. CT abdomen to count packets. Surgical team on standby. If packet ruptures: immediate life-threatening emergency.

Gastric Lavage

Rarely Used

Indications (Narrow)

  • Massive potentially fatal ingestion within 1 hour
  • No adequate alternative (agent not charcoal-responsive)
  • Discuss with toxicologist before proceeding

Procedure Requirements

  • GCS <8: cuffed ETT must be in place first
  • Left lateral, head-down position
  • 36-40Fr orogastric tube
  • Aliquots 250ml warm water, aspirate, repeat
  • Total lavage fluid: 10-15L until clear

Complications

  • Aspiration (most serious)
  • Laryngospasm, oesophageal perforation
  • Electrolyte imbalance, hypothermia

Ipecac Syrup & Cathartics

Ipecac Syrup: NOT RECOMMENDED — no evidence of improved outcomes, delayed charcoal administration, aspiration risk, cardiac toxicity (emetine). Withdrawn from use in most countries.

Cathartics (sorbitol/magnesium sulphate): No evidence of clinical benefit. Associated with dehydration and electrolyte imbalance. Not recommended as routine adjunct.

Paracetamol NAC Protocol — Full Detail

Assessment & Nomogram

  • Take paracetamol level at 4 hours post-ingestion (earliest reliable time)
  • Plot on Rumack-Matthew nomogram
  • Treatment line: 150mg/L at 4 hours
  • If <4 hours: treat empirically if >150mg/kg or 7.5g ingested
  • Staggered overdose: nomogram unreliable — if any dose interval >1hr, treat if total dose >150mg/kg

Risk Factors for Increased Toxicity

  • Chronic alcohol use, malnutrition, eating disorders
  • Enzyme-inducing drugs (phenytoin, rifampicin, carbamazepine)
  • HIV on enzyme-inducing ART
  • Depleted glutathione stores

3-Bag NAC Protocol (Traditional)

  1. Bag 1: 150mg/kg in 200ml 5% dextrose over 1 hour
  2. Bag 2: 50mg/kg in 500ml 5% dextrose over 4 hours
  3. Bag 3: 100mg/kg in 1000ml 5% dextrose over 16 hours
  4. Total dose: 300mg/kg over 21 hours

SNAP Protocol (Simplified NAC)

  • 2-bag: Loading 200mg/kg over 4 hours, then 100mg/kg over 16 hours
  • Reduced anaphylactoid reactions vs traditional 3-bag
  • Check local/regional protocol — both in use

Monitoring During NAC

  • LFTs, INR, U&E, creatinine at 0, 4, 16, 21 hours
  • If ALT rising or INR >2: extend NAC and refer hepatology
  • Anaphylactoid reaction: stop infusion, give antihistamine, restart at slower rate

King's College Criteria (liver transplant referral): Arterial pH <7.3 after resuscitation, OR all three of: INR >6.5 + creatinine >300 + grade III-IV encephalopathy.

Opioid Overdose

Naloxone Dosing

RouteDoseOnset
IV0.4–2mg, repeat q2–3min~2 min
IM/SC0.4–0.8mg~5 min
Intranasal2mg (1mg per nostril)~8 min
Infusion2/3 effective dose/hrContinuous

Key Principles

  • Titrate to RR >12, NOT full reversal — avoids precipitating acute withdrawal
  • Half-life of naloxone (~60-90min) often shorter than opioid — re-dosing or infusion required
  • Long-acting opioids (methadone, buprenorphine, SR morphine): extended monitoring 12-24hrs
  • Tramadol: partial response to naloxone; also lowers seizure threshold
  • Fentanyl analogues: may need higher doses

Withdrawal precipitated by naloxone: agitation, tachycardia, vomiting, diaphoresis — supportive management. Withdrawal is rarely life-threatening but opioid toxicity is.

Benzodiazepine Overdose

Flumazenil — Use with Extreme Caution

Indications

  • Pure benzodiazepine overdose for reversal of sedation
  • Procedural reversal in known patients

Dose

  • 0.2mg IV over 15 seconds, then 0.1mg q60sec up to 1mg
  • Short-acting: 1-2 hours — repeat dosing may be needed

CONTRAINDICATIONS: Mixed overdose (TCA co-ingestion — seizure risk), chronic benzodiazepine users (withdrawal seizures), raised ICP, known seizure disorder. Most ED overdoses: flumazenil is NOT routinely used.

Organophosphate Poisoning

Atropine Protocol

  • Goal: dry secretions (not pupil size or HR)
  • Initial: 2–4mg IV, double dose every 5 minutes until secretions controlled
  • Severe cases: up to 20–100mg may be required
  • Infusion: 10–20% of loading dose per hour
  • Endpoint: dry lungs on auscultation, secretions reduced

Pralidoxime (PAM)

  • Reactivates acetylcholinesterase — give within 24-48 hours (before ageing)
  • Dose: 1–2g IV over 15-30min, then 500mg/hr infusion
  • Effective for nicotinic (muscle weakness) effects
  • Does not replace atropine

Staff PPE essential. Organophosphate absorbed dermally — remove patient's clothing, wash skin with soap and water. Avoid contaminating resuscitation room.

Tricyclic Antidepressant (TCA) Overdose

Features

  • Anticholinergic + sodium channel blockade + alpha-blockade
  • Wide QRS >100ms: high-risk for arrhythmia
  • R wave in aVR >3mm: predictive of seizures/arrhythmia
  • Rapidly deteriorating — can arrest within minutes

Sodium Bicarbonate Indications

  • QRS >100ms or arrhythmia
  • Hypotension refractory to fluids
  • Dose: 1–2mmol/kg IV bolus, repeat to pH 7.45–7.55
  • Infusion: 150mmol in 1L 5% dextrose

Avoid: physostigmine (seizures), flumazenil (seizure risk), fluids alone for hypotension. Seizure: benzodiazepine first-line. Avoid phenytoin (cardiac toxicity). Early intubation if deteriorating.

Beta-Blocker & CCB Overdose

High-Dose Insulin Euglycaemia Therapy (HIET)

  • Dose: Insulin 1 unit/kg bolus, then 0.5–2 units/kg/hr
  • Dextrose 50%: 50ml bolus, then 10% dextrose infusion to maintain BM 8-14
  • BM every 15-30 min; K+ every 30-60 min
  • May take 20-30min to see effect

Additional Agents

  • Calcium: Calcium chloride 10ml 10% IV (CCB preferred) — repeat q10-20min
  • Glucagon: 5-10mg IV bolus, then 2-5mg/hr infusion (beta-blocker)
  • Lipid emulsion (intralipid 20%): refractory cardiac toxicity — 1.5ml/kg bolus
  • Atropine: Bradycardia (limited efficacy)
  • Pacing: Transcutaneous/transvenous if pharmacotherapy fails

Digoxin & Iron Toxicity

Digoxin — Fab Fragments (Digibind/DigiFab)

  • Indications: life-threatening arrhythmia, K+ >5.5mmol/L with toxicity, haemodynamic instability
  • Dose calculation: based on digoxin level or estimated ingestion
  • Empirical: 10 vials if massive OD; cardiac arrest: 20 vials
  • Post-Fab: digoxin levels unreliable; monitor K+ (may fall rapidly)

Iron Overdose — Desferrioxamine

  • Indications: serum iron >500mcg/dL, severe symptoms, acidosis
  • Dose: 15mg/kg/hr IV infusion (max 80mg/kg/day)
  • Urine: pink/rose "vin rose" colour = free iron present
  • Abdominal XR: radiopaque tablets visible
  • WBI for significant iron ingestion

Cyanide — Hydroxocobalamin

  • Hydroxocobalamin (Cyanokit): 5g IV over 15 min — first-line in smoke inhalation/suspected cyanide
  • Sodium thiosulphate: 12.5g IV — adjunct
  • Skin/urine turns red — warn patient
  • Do NOT use dicobalt edetate unless diagnosis certain (cardiac toxicity if no cyanide)
Carbon Monoxide Poisoning Protocol

Pathophysiology & Presentation

  • CO binds haemoglobin with 240x affinity of O2 → left shift of O2-Hb curve
  • Symptoms vary with COHb level:
COHb %Symptoms
10-20%Headache, nausea, exertional dyspnoea
20-40%Severe headache, syncope, confusion
40-60%Seizures, coma, cardiopulmonary compromise
>60%Fatal

Pulse oximetry UNRELIABLE — reads COHb as OxyHb. Use co-oximetry ABG for true saturation.

Treatment

100% Oxygen via NRB

  • Reduces COHb half-life: room air ~4-5hr → 100% O2 ~60-90min
  • Continue until COHb <5% and symptoms resolved

Hyperbaric Oxygen (HBO) Indications

  • COHb >25% at any time
  • Cardiac effects (arrhythmia, ischaemic ECG changes)
  • Pregnancy — any symptomatic CO poisoning (lower threshold)
  • Neurological symptoms (seizure, syncope, focal deficit)
  • Age >36, or COHb >25 in children

Late Neurological Sequelae

  • Delayed neuropsychological syndrome: 10-30% of serious poisonings
  • 2-4 weeks after apparent recovery
  • Features: cognitive impairment, personality change, Parkinsonism
  • HBO may reduce incidence

Alcohol Poisoning

Ethanol Toxicity

  • CNS depression, respiratory depression, aspiration risk
  • Hypoglycaemia (inhibits gluconeogenesis) — BM stat
  • Hypothermia — monitor temperature actively
  • Co-ingestion common — thorough history required

Wernicke's Encephalopathy Prevention

  • Risk in: chronic alcohol use, malnourished, any vomiting
  • Give IV Pabrinex BEFORE glucose — glucose alone may precipitate Wernicke's
  • Pabrinex: 2 pairs (4 ampoules) IV in 100ml NaCl over 30min
  • Classic triad: confusion + ophthalmoplegia + ataxia (often incomplete)
  • If in doubt: give thiamine — it is safe

Methanol / Ethylene Glycol

  • High anion gap metabolic acidosis, raised osmolar gap
  • Methanol: visual disturbance, papilloedema
  • Antidote: Fomepizole (4-methylpyrazole) — blocks alcohol dehydrogenase
  • Ethanol infusion if fomepizole unavailable
  • Haemodialysis for severe acidosis or visual loss

Lithium Toxicity

Features

  • Acute: GI (nausea/vomiting/diarrhoea) — relatively protected from CNS
  • Chronic: neurological features dominate — tremor, confusion, seizures, nephrogenic DI
  • Acute on chronic: mixed picture, most dangerous

Levels & Management

Level (mmol/L)Action
1.5–2.0Mild toxicity — monitoring, fluids
2.0–2.5Moderate — IV fluids, WBI if SR tablets
>2.5 or symptomaticHaemodialysis consideration

Haemodialysis Indications

  • Level >4 mmol/L regardless of symptoms
  • Level >2.5 with severe symptoms (seizures, coma)
  • Renal failure preventing excretion
  • Rebound rise after HD — repeat sessions may be needed

Salicylate (Aspirin) Poisoning

Clinical Features

  • Early: tinnitus, deafness, nausea, vomiting
  • Hyperventilation → respiratory alkalosis → metabolic acidosis
  • Hyperthermia, diaphoresis, dehydration
  • Severe: confusion, pulmonary oedema, CNS depression — very high mortality

Key Investigations

  • Serial salicylate levels (q2h) — levels may rise with SR formulations
  • Levels >700mg/L (symptomatic) or >900mg/L: haemodialysis
  • ABG: respiratory alkalosis + metabolic acidosis
  • Glucose (hypoglycaemia in CNS despite normal plasma glucose)

Urinary Alkalinisation

  • Target urine pH 7.5–8.5 — ionises salicylate, prevents renal reabsorption
  • Sodium bicarbonate 225mmol in 500ml 5% dextrose over 3hrs
  • Add 40mmol KCl — hypokalaemia prevents alkalinisation
  • Monitor urine pH hourly; serum K+ 2 hourly

Haemodialysis Indications

  • Salicylate level >900mg/L (6.5mmol/L)
  • Severe metabolic acidosis not responding
  • Acute kidney injury
  • Pulmonary oedema, CNS toxicity
  • Unable to tolerate alkalinisation (heart failure)

Risk Assessment After Overdose

Immediate Medical Assessment

  • Medical stability must be established before psychiatric assessment
  • Paracetamol level in all deliberate overdoses regardless of stated dose
  • Document time of ingestion, agent, amount, circumstances

Suicide Risk Factors

  • Previous attempts (strongest predictor)
  • Male sex, age >45, social isolation
  • Mental illness (depression, psychosis, substance use)
  • Lethal method, planning, leaving note
  • Expressed intent to die; no regret
  • Access to means (stockpiling, weapons)

Protective Factors

  • Social support, family engagement
  • Future orientation, reasons for living
  • Help-seeking behaviour, ambivalence
  • Religious/cultural beliefs against suicide

Capacity Assessment for Treatment Refusal

Mental Capacity Assessment (4-Stage Test)

  1. Understand the information provided
  2. Retain it long enough to make decision
  3. Weigh up the information
  4. Communicate a decision

Key Principles

  • Capacity is decision-specific and time-specific
  • Assume capacity unless proven otherwise
  • Impaired capacity from drugs/alcohol/medical condition: treat in best interests
  • Document assessment fully including reasoning
  • Involve senior clinician and legal/ethics if contentious

Refusing NAC for paracetamol overdose: assess capacity; if lacking, treat. If patient has capacity, document refusal, explore reasons, contact psychiatry. Never abandon patient.

Psychiatric Assessment & Referral

Collaborative Approach

  • Psychiatric liaison team involvement: all deliberate self-harm
  • Assessment should not be rushed due to ED pressures
  • Private, quiet space — trauma-informed communication
  • Avoid judgement; use open questions
  • Paracetamol with intent vs impulsive: risk stratification differs

MHAA Referral (Mental Health Act Assessment)

  • Indicated when patient poses imminent risk and lacks capacity or refuses
  • Involves Approved Mental Health Professional (AMHP) + 2 doctors
  • Section 5(2): nurse holding power (up to 6 hours in inpatient)
  • Document all observations, clinical reasoning, communication

Safe Prescribing Post-Discharge

  • Limit quantities: paracetamol 16 tablets OTC; prescription limited quantities
  • Blister packs rather than bottles — reduces impulsive access
  • Safety plan with patient before discharge
  • Crisis line numbers provided

Safeguarding & CAMS Framework

Safeguarding Vulnerable Adults

  • Older adults, those with learning disability, domestic abuse victims
  • Coercion or control by others (forced ingestion)
  • Refer to safeguarding team before discharge
  • Document: who was present, who accompanied patient

Children & Adolescents (CAMHS/CAMS)

  • CAMS (Collaborative Assessment and Management of Suicidality) framework
  • Age-appropriate communication; involve parents/carers appropriately
  • Gillick competence for 16+ or mature minor
  • School-age: safeguarding referral, liaise with paediatric team
  • Never discharge a child at risk without CAMHS review

Psychological First Aid in ED

  • Look, Listen, Link — immediate psychosocial support
  • Normalise distress; non-judgmental language
  • Avoid repeated retelling of traumatic history in ED
  • Ensure physical privacy; offer food/water
  • Peer support workers valuable in some settings

GCC-Specific Poisoning Contexts

Organophosphate Poisoning

  • Significant in South Asian migrant agricultural workers across GCC states
  • Common agents: chlorpyrifos, malathion, diazinon (crop pesticides)
  • Occupational exposure + accidental self-poisoning
  • Language barrier may delay history — use interpreters
  • Cultural stigma may delay seeking care

Domestic Workers & Medication Overdose

  • Paracetamol and TCA overdose reported in domestic worker populations
  • Social isolation, labour exploitation, limited healthcare access as risk factors
  • Human rights and safeguarding considerations
  • Notify social work / embassy liaison as appropriate

Carbon Monoxide from Gas Heaters

  • CO poisoning from unventilated gas heaters in workers' accommodation
  • Multiple casualties possible — co-workers affected simultaneously
  • Winter months: highest risk in GCC states
  • Mass casualty protocol if group presentation

GCC-Specific Clinical Considerations

Heat Stroke vs Drug Hyperthermia

FeatureHeat StrokeDrug Hyperthermia
ContextExertion, hot environmentDrug ingestion history
SweatingAbsent (classic)Present (serotonin/sympathomimetic)
SkinHot, dryVariable (anticholinergic: dry)
NeuromuscularAbsent clonusClonus/rigidity (serotonin/NMS)
CKElevatedElevated (NMS, serotonin)

Ramadan Fasting & Medication Error

  • Timing confusion with dose schedule during fasting hours
  • Insulin: hypoglycaemia risk from missed meals
  • Twice-daily medications taken together at Iftar or Suhoor
  • Modified-release: doubling of doses
  • Proactive patient education before Ramadan — pharmacist-led medication review
  • Nurse's role: identify unintentional overdose presentation during Ramadan

TOXBASE Access & Poison Control in GCC

UAE Resources

  • UAE National Poison Control Centre — DHA/MOH integrated
  • 24hr telephone toxicology advisory available in major UAE hospitals
  • TOXBASE (UK) accessible in many GCC hospital formularies via subscription
  • Clinical pharmacist toxicology support in tertiary centres

Regional Contacts

  • Saudi Arabia: King Faisal Specialist Hospital Poison Control Centre
  • Kuwait: Kuwait Poison Control Centre
  • Qatar: Hamad General Hospital Emergency Toxicology

Nursing Documentation in GCC Context

  • Document capacity assessment and consent in all overdose cases
  • Psychiatric referral pathway — note local HAAD/DHA protocol
  • Immigration/visa status does not affect right to emergency care
  • Interpreter services: document language used and interpreter ID
  • Cross-border medications: unfamiliar formulations — use TOXBASE

DHA / DOH / SCFHS Exam Preparation

NAC Protocol — Exam Key Points

  • Take paracetamol level at 4 hours minimum
  • Treatment line: 150mg/L at 4 hours
  • 3-bag protocol total dose: 300mg/kg over 21 hours
  • Bag 1: 150mg/kg over 1 hour
  • Staggered OD: treat if >150mg/kg regardless of level
  • King's College Criteria: pH <7.3 OR INR >6.5 + Cr >300 + encephalopathy grade III-IV

Antidote Matching — High Yield

  • Paracetamol → NAC (acetylcysteine)
  • Opioid → Naloxone
  • Organophosphate → Atropine + Pralidoxime
  • TCA → Sodium bicarbonate
  • Digoxin → Fab fragments
  • Benzo → Flumazenil (with caution)
  • CO → 100% O2 / HBO
  • Iron → Desferrioxamine
  • Cyanide → Hydroxocobalamin
  • Beta-blocker/CCB → HIET / Calcium / Glucagon

Activated Charcoal — Exam Traps

  • NOT for: iron, lithium, alcohols, corrosives, hydrocarbons
  • Dose: 50g adults, 1g/kg children
  • Within 1 hour of ingestion
  • Unconscious = contraindicated unless intubated

Flumazenil Cautions

  • Never give in mixed overdose with TCA
  • Seizure risk in chronic benzo users
  • Short-acting — re-sedation possible

Naloxone Key Points

  • Titrate to RR not full reversal
  • Long-acting opioids: infusion needed
  • Half-life shorter than most opioids

Interactive Antidote Matcher

Select a poisoning agent to view the specific antidote, dosing, monitoring, and key nursing actions.